Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Pivotal Study in HER2 Negative, Locally Recurrent or Metastatic Breast Cancer (FORTRESS)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03786094
Recruitment Status : Active, not recruiting
First Posted : December 24, 2018
Last Update Posted : November 30, 2020
Sponsor:
Information provided by (Responsible Party):
Polyphor Ltd.

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Estimated Primary Completion Date : March 2021
Estimated Study Completion Date : March 2022